Characteristics Predicting Tuberculosis Risk under Tumor Necrosis Factor-alpha Inhibitors: Report from a Large Multicenter Cohort with High Background Prevalence
Tarih
2016Yazar
Dalkilic, Ediz
Pehlivan, Yavuz
KILIÇ, LEVENT
Ertenli, Ihsan
Direskeneli, Haner
Keser, Gokhan
Ozguler, Yesim
Erer, Sait Burak
Oksel, Fahrettin
Onat, Ahmet Mesut
YILMAZ, Sedat
PAY, Salih
Balkarli, Ayse
Cobankara, Veli
Cetin, Gode Yildirim
Sayarlioglu, Mehmet
Cefle, Ayse
Yazici, Ayten
AVCI, Ali Berkant
Terzioglu, Ender
Ozbek, Suleyman
Akar, Servet
Kisacik, Bunyamin
Pamuk, Omer Nuri
Gul, Ahmet
Hatemi, Gulen
Can, Meryem
Üst veri
Tüm öğe kaydını gösterÖzet
Objective. Screening strategies for latent tuberculosis (TB) before starting tumor necrosis factor (TNF)-alpha inhibitors have decreased the prevalence of TB among patients who are treated with these agents. However, despite vigilant screening, TB continues to be an important problem, especially in parts of the world with a high background TB prevalence. The aim of this study was to determine the factors related to TB among a large multicenter cohort of patients who were treated with anti-TNF.
Koleksiyonlar
- Makale [92796]